Expression of ss-tubulin isotypes in classical Hodgkin's lymphoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Jung-Woo | - |
dc.contributor.author | Lee, Ju-Han | - |
dc.contributor.author | Kim, Young-Sik | - |
dc.date.accessioned | 2021-09-06T21:36:08Z | - |
dc.date.available | 2021-09-06T21:36:08Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2012-04 | - |
dc.identifier.issn | 1320-5463 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/108779 | - |
dc.description.abstract | Microtubules consist of heterodimers of a- and b-tubulin. Aberrant expression of specific b-tubulin isotype is associated with resistance to chemotherapy in malignant tumors. In this study, we examined the expressions of b-tubulin isotypes in classical Hodgkin's lymphoma (cHL) by immunohistochemistry. Among the b-tubulin isotypes, class II b-tubulin (31/34, 91%) was most frequently overexpressed in the cytoplasm of almost all Hodgkin's and Reed-Sternberg (HRS) cells, followed by class I b-tubulin (18/34, 53%) and class III b-tubulin (12/34, 35%). Class IV b-tubulin was not expressed in any cHL case. Class I b-tubulin was expressed in the background lymphoid cells as well as the HRS cells. Thus, our results indicate that class II b-tubulin may be very useful for immunohistochemical diagnosis of cHL, and provide valuable information for the potential application of b-tubulin isotype-specific targeting. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY-BLACKWELL | - |
dc.subject | BINDING AGENTS | - |
dc.subject | BETA-TUBULIN | - |
dc.subject | CLASS-II | - |
dc.subject | RESISTANCE | - |
dc.subject | BIOLOGY | - |
dc.subject | CELLS | - |
dc.title | Expression of ss-tubulin isotypes in classical Hodgkin's lymphoma | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Jung-Woo | - |
dc.contributor.affiliatedAuthor | Lee, Ju-Han | - |
dc.contributor.affiliatedAuthor | Kim, Young-Sik | - |
dc.identifier.doi | 10.1111/j.1440-1827.2011.02785.x | - |
dc.identifier.scopusid | 2-s2.0-84862810270 | - |
dc.identifier.wosid | 000302016700010 | - |
dc.identifier.bibliographicCitation | PATHOLOGY INTERNATIONAL, v.62, no.4, pp.287 - 290 | - |
dc.relation.isPartOf | PATHOLOGY INTERNATIONAL | - |
dc.citation.title | PATHOLOGY INTERNATIONAL | - |
dc.citation.volume | 62 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 287 | - |
dc.citation.endPage | 290 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pathology | - |
dc.relation.journalWebOfScienceCategory | Pathology | - |
dc.subject.keywordPlus | BINDING AGENTS | - |
dc.subject.keywordPlus | BETA-TUBULIN | - |
dc.subject.keywordPlus | CLASS-II | - |
dc.subject.keywordPlus | RESISTANCE | - |
dc.subject.keywordPlus | BIOLOGY | - |
dc.subject.keywordPlus | CELLS | - |
dc.subject.keywordAuthor | Hodgkin&apos | - |
dc.subject.keywordAuthor | s lymphoma | - |
dc.subject.keywordAuthor | microtubule | - |
dc.subject.keywordAuthor | tubulin | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.